Product
Fisogatinib
Aliases
BLU-554, Fisogatinib (BLU-554)
Name
BLU-554
1 clinical trial
1 indication
2 posters
Indication
Hepatocellular CarcinomaClinical trial
A Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of BLU-554 in Patients With Hepatocellular CarcinomaStatus: Completed, Estimated PCD: 2021-06-30